Evidence Hub

Topiramate's ocular trap: acute angle closure rescued by early systemic steroid therapy

Gupta M, Singh A, Singh K, Jain S

BMJ case reports, 2026

Abstract

A woman in her 30s presented with sudden bilateral vision loss, ocular pain, headache, nausea and vomiting. She had been taking topiramate for migraine prophylaxis for 10 days. Examination revealed shallow anterior chambers and intraocular pressure (IOP) of 59 mm Hg OD and 55 mm Hg OS, with appositional angle closure. Anterior segment optical coherence tomography confirmed closed angles and ultrasound biomicroscopy revealed ciliary body effusion. A diagnosis of topiramate-induced acute angle closure was made. Prompt treatment with systemic and topical steroids, cycloplegics, mannitol and topical anti-glaucoma drugs led to rapid improvement in vision and IOP within 6 hours. Full recovery was achieved by day 3. Acetazolamide triggered a recurrence of elevated IOP. This case highlights the importance of early initiation of systemic steroids, which can result in rapid anatomical and functional recovery, and underscores the potential for acetazolamide to worsen angle closure in such cases.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free